1. Home
  2. CRBU vs INTT Comparison

CRBU vs INTT Comparison

Compare CRBU & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • INTT
  • Stock Information
  • Founded
  • CRBU 2011
  • INTT 1981
  • Country
  • CRBU United States
  • INTT United States
  • Employees
  • CRBU N/A
  • INTT N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • INTT Semiconductors
  • Sector
  • CRBU Health Care
  • INTT Technology
  • Exchange
  • CRBU Nasdaq
  • INTT Nasdaq
  • Market Cap
  • CRBU 93.0M
  • INTT 77.3M
  • IPO Year
  • CRBU 2021
  • INTT 1997
  • Fundamental
  • Price
  • CRBU $1.06
  • INTT $6.05
  • Analyst Decision
  • CRBU Strong Buy
  • INTT Strong Buy
  • Analyst Count
  • CRBU 4
  • INTT 2
  • Target Price
  • CRBU $8.50
  • INTT $12.00
  • AVG Volume (30 Days)
  • CRBU 943.1K
  • INTT 50.1K
  • Earning Date
  • CRBU 05-08-2025
  • INTT 05-02-2025
  • Dividend Yield
  • CRBU N/A
  • INTT N/A
  • EPS Growth
  • CRBU N/A
  • INTT N/A
  • EPS
  • CRBU N/A
  • INTT N/A
  • Revenue
  • CRBU $9,918,000.00
  • INTT $127,503,000.00
  • Revenue This Year
  • CRBU N/A
  • INTT N/A
  • Revenue Next Year
  • CRBU $161.81
  • INTT $10.07
  • P/E Ratio
  • CRBU N/A
  • INTT N/A
  • Revenue Growth
  • CRBU N/A
  • INTT 5.19
  • 52 Week Low
  • CRBU $0.66
  • INTT $5.24
  • 52 Week High
  • CRBU $3.00
  • INTT $11.92
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 56.92
  • INTT 46.96
  • Support Level
  • CRBU $0.98
  • INTT $5.64
  • Resistance Level
  • CRBU $1.21
  • INTT $6.50
  • Average True Range (ATR)
  • CRBU 0.10
  • INTT 0.29
  • MACD
  • CRBU 0.02
  • INTT 0.04
  • Stochastic Oscillator
  • CRBU 65.99
  • INTT 51.09

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.

Share on Social Networks: